Key facts
- Phyta Biodesign’s last known valuation is $1.6M (Apr 2025).
- It has raised $360K; the latest was Accelerator/Incubator in Jun 2025.
- Notable investors include SFC Capital, Enterprise Nation, New European Bauhaus.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Phyta Biodesign
- ·The full record, as it builds
Funding rounds
No funding rounds for Phyta Biodesign are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Phyta Biodesign
Developer of architectural systems designed for biodiversity integration in urban spaces. The company's platform combines digital design methods, modular fabrication, and ecological research to create facade structures that support native species, incorporate planting and habitat elements into built environments, and adapt to various architectural contexts, enabling urban areas to support biodiversity and promote coexistence between human and non-human inhabitants.
- Sector
- Business Products and Services (B2B)
- HQ
- London, United Kingdom
- Founded
- 2022
- Employees
- 3
- Website
- phytadesign.com/
- Ownership
- Privately Held (backing)
Phyta Biodesign doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Phyta Biodesign shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Phyta Biodesign in its N-PORT filings yet. We sweep new filings monthly.